Impact of degree of obesity on surrogate estimates of insulin resistance

Diabetes Care

Volumn 27, Issue 8, 2004, Pages 1998-2002

  Kim, Sun H ^a   Abbasi, Fahim ^a   Reaven, Gerald M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; OCTREOTIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE MARKER; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; QUANTITATIVE ASSAY; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; STEADY STATE; UNITED STATES;

BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES;

EID: 3342971027     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.8.1998     Document Type: Article

References (35)

1. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174, 1989
4. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
5. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN: Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183-1192, 2001
6. Shen SW, Reaven GM, Farquhar JW: Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 49:2151-2160, 1970
7. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
8. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
10. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410, 2000
11. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM: Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23: 171-175, 2000
12. Abbasi F, Reaven GM: Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 51:235-237, 2002
13. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity: European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100: 1166-1173, 1997
14. Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM: Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278:E501-E508, 2000
15. Ferrannini E, Balkau B: Insulin: in search of a syndrome. Diabet Med 19:724-729, 2002
16. Bastard JP, Rabasa-Lhoret R, Maachi M, Ducluzeau PH, Andreelli F, Vidal H, Laville M: What kind of simple fasting index should be used to estimate insulin sensitivity in humans? Diabetes Metab 29: 285-288, 2003
17. Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F, Bruzeau J, Louche-Pellissier C, Maltrepierre C, Peyrat J, Chagne J, Vidal H, Laville M: Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 88:4917-4923, 2003
18. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63, 2000
19. Gonzalez-Ortiz M, Martinez-Abundis E: Comparison of several formulas to assess insulin action in the fasting state with the hyperglycemic- hyperinsulinemic clamp technique in healthy individuals. Rev Invest Clin 55:419-422, 2003
20. Lansang MC, Williams GH, Carroll JS: Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am J Hypertens 14:51-53, 2001
21. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS, Marks JB: Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 47:177-184, 2000
22. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200, 2001
23. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH: Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 288: 1758-1761, 2002
24. Haffner S, Taegtmeyer H: Epidemic obesity and the metabolic syndrome. Circulation 108:1541-1545, 2003
25. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
26. Pei D, Jones CN, Bhargava R, Chen YD, Reaven GM: Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37:843-845, 1994
27. Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G: Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30:387-392, 1981
28. Walker H, Lev J: Statistical Inference. New York, Holt, Rinehart, and Winston, 1953
29. Elahi D, Nagulesparan M, Hershcopf RJ, Muller DC, Tobin JD, Blix PM, Rubenstein AH, Unger RH, Andres R: Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med 306:1196-1202, 1982
30. Bonora E, Zavaroni I, Bruschi F, Alpi O, Pezzarossa A, Guerra L, Dall'Aglio E, Coscelli C, Butturini U: Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab 59: 1121-1127, 1984
31. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E: Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435-441, 1988
32. Meistas MT, Margolis S, Kowarski AA: Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Physiol 245:E155-E159, 1983
33. Reaven GM, Moore J, Greenfield M: Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance. Diabetes 32:600-604, 1983
34. Abbasi F, Brown BW, Jr, Lamendola C, McLaughlin T, Reaven GM: Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40:937-943, 2002
35. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, Quon MJ, Baron AD: Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 86:5457-5464, 2001